---
figid: PMC5101236__fphar-07-00428-g0001
figtitle: Schematic signaling pathways elicited by VEGF
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5101236
filename: fphar-07-00428-g0001.jpg
figlink: /pmc/articles/PMC5101236/figure/F1/
number: F1
caption: Schematic signaling pathways elicited by VEGF. The Tyrosine kinase proteins,
  Serine/Threonine Kinase (AKT etc), and GTPase (K-Ras) pathways are illustrated inside
  the cytoplasm compartment. The drugs (blu boxes) are indicative for their target
  that blocks/inhibit their effect on neo-angiogenesis, cell proliferation, apoptosis
  and etc. VEGFR family is composed by VEGFR1 (Alias FLT1), VEGFR2 (Alias KDR), VEGFR3
  (Alias NRP1). Receptors for growth factors (VEGFR, FGFR, PDGFR) activate intracellular
  receptor tyrosine kinases (RTKs) and the downstream RAS/RAF/mitogen-activated protein
  extracellular kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling
  pathway, and promote the growth, migration and morphogenesis of vascular endothelial
  cells, thus increasing vascular permeability by activating nuclear proteins (yellow
  boxes). Angiopoietin 1, 2 (Tie1,2) and VEGF are the principal angiogenic growth
  factors.
papertitle: Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma.
reftext: Massimiliano Berretta, et al. Front Pharmacol. 2016;7:428.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9396836
figid_alias: PMC5101236__F1
figtype: Figure
redirect_from: /figures/PMC5101236__F1
ndex: e59180b2-df05-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5101236__fphar-07-00428-g0001.html
  '@type': Dataset
  description: Schematic signaling pathways elicited by VEGF. The Tyrosine kinase
    proteins, Serine/Threonine Kinase (AKT etc), and GTPase (K-Ras) pathways are illustrated
    inside the cytoplasm compartment. The drugs (blu boxes) are indicative for their
    target that blocks/inhibit their effect on neo-angiogenesis, cell proliferation,
    apoptosis and etc. VEGFR family is composed by VEGFR1 (Alias FLT1), VEGFR2 (Alias
    KDR), VEGFR3 (Alias NRP1). Receptors for growth factors (VEGFR, FGFR, PDGFR) activate
    intracellular receptor tyrosine kinases (RTKs) and the downstream RAS/RAF/mitogen-activated
    protein extracellular kinase (MEK)/extracellular signal-regulated kinase (ERK)
    signaling pathway, and promote the growth, migration and morphogenesis of vascular
    endothelial cells, thus increasing vascular permeability by activating nuclear
    proteins (yellow boxes). Angiopoietin 1, 2 (Tie1,2) and VEGF are the principal
    angiogenic growth factors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - KDR
  - NRP1
  - NELL1
  - FLT1
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - MET
  - SOS1
  - KRAS
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - BRAF
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RORC
  - JUN
  - JUNB
  - JUND
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - MYC
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - Brivanib
  - Nintedanib
  - Regorafenib
  - Cancer
---
